Cited by 342Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

19F and 1H MRI detection of amyloid β plaques in vivo

Higuchi, Makoto, Iwata, Nobuhisa, Matsuba, Yukio, Sato, Kumi, Sasamoto, Kazumi, Saido, Takaomi C·2005·Nature Neuroscience

DOI 10.1038/nn1422

Open this paper in CoChat — free account

Abstract

Formation of senile plaques composed of amyloid beta peptide, a pathological hallmark of Alzheimer disease, in human brains precedes disease onset by many years. Noninvasive detection of such plaques could be critical in presymptomatic diagnosis and could contribute to early preventive treatment strategies. Using amyloid precursor protein (APP) transgenic mice as a model of amyloid beta amyloidosis, we demonstrate here that an intravenously administered (19)F-containing amyloidophilic compound labels brain plaques and allows them to be visualized in living mice by magnetic resonance imaging (MRI) using (19)F and (1)H. Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. This approach could be used in longitudinal studies in mouse models of Alzheimer disease to search for biomarkers associated with amyloid beta pathology as well as to track disease course after treatment with candidate medications.

Integrity signals

Registry

Crossref · 10.1038/nn1422

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,088
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Although plaques by themselves may not be a direct cause of Alzheimer disease symptoms, a noninvasive method to detect them in the brain will allow diagnosis and preventive treatment of affected individuals before neurological symptoms and irreversible neurodegeneration occu”
Method
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer Disease
Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and, & National Institute on Aging Working Group (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 719
Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587

Show all 32 references

Sorted by citations

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Challenges for Molecular Magnetic Resonance Imaging
Terreno, E., Castelli, D. D., Viale, A., & Aime, S. (2010) · Chemical Reviews · doi:10.1021/cr100025t · Cited by 852
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Advanced functional materials based on polyhedral oligomeric silsesquioxane (POSS)
Tanaka, K., & Chujo, Y. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm14231c · Cited by 490
Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-β Deposits
Ran, C., Xu, X., Raymond, S. B., Ferrara, B. J., Neal, K. L., Bacskai, B. J., Medarova, Z. O., & Moore, A. V. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9047043 · Cited by 486
Congo red and protein aggregation in neurodegenerative diseases
Frid, P., Anisimov, S. V., & Popović, N. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.001 · Cited by 405
Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer’s Disease
Zhang, X., Tian, Y., Zeng, L., Tian, X., Sun, H., Liu, H., Moore, A. V., & Ran, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405239v · Cited by 354
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography
Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0673-07.2007 · Cited by 300
Self-citation
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
Paramagnetic Relaxation-Based 19F MRI Probe To Detect Protease Activity
Mizukami, S., Takikawa, R., Sugihara, F., Hori, Y., Tochio, H., Walchli, M. R., Shirakawa, M., & Kikuchi, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja077058z · Cited by 254
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 242
Self-assembling nanoprobes that display off/on 19F nuclear magnetic resonance signals for protein detection and imaging
Takaoka, Y., Sakamoto, T., Tsukiji, S., Narazaki, M., Matsuda, T., Tochio, H., Shirakawa, M., & Hamachi, I. (2009) · Nature Chemistry · doi:10.1038/nchem.365 · Cited by 231
Metabolism of amyloid-β peptide and Alzheimer's disease
Iwata, N., Higuchi, M., & Saido, T. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.010 · Cited by 216
Site-Specific Incorporation of a 19F-Amino Acid into Proteins as an NMR Probe for Characterizing Protein Structure and Reactivity
Jackson, J. C., Hammill, J. T., & Mehl, R. A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja064661t · Cited by 211
In vivo imaging of the diseased nervous system
Misgeld, T., & Kerschensteiner, M. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1905 · Cited by 198
New frontiers and developing applications in 19F NMR
Yu, J.-X., Hallac, R. R., Chiguru, S., & Mason, R. P. (2012) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2012.10.001 · Cited by 198
Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
Hane, F. T., Robinson, M. J., Lee, B. Y., Bai, O., Leonenko, Z., & Albert, M. S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160907 · Cited by 211
Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
Schön, C., Hoffmann, N. A., Ochs, S. M., Burgold, S., Filser, S., Steinbach, S., Seeliger, M. W., Arzberger, T., Goedert, M., Kretzschmar, H. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053547 · Cited by 193
Propagation of pathological α-synuclein in marmoset brain
Shimozawa, A., Ono, M., Takahara, D., Tarutani, A., Imura, S., Masuda‐Suzukake, M., Higuchi, M., Yanai, K., Hisanaga, S., & Hasegawa, M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0413-0 · Cited by 204
BODIPY-Based Molecular Probe for Imaging of Cerebral β-Amyloid Plaques
Ono, M., Watanabe, H., Kimura, H., & Saji, H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000058 · Cited by 164
Preparation of site-specifically labeled fluorinated proteins for 19F-NMR structural characterization
Hammill, J. T., Miyake-Stoner, S. J., Hazen, J. L., Jackson, J. C., & Mehl, R. A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.379 · Cited by 158
The Amyloid–Congo Red Interface at Atomic Resolution
Schütz, A. K., Soragni, A., Hornemann, S., Aguzzi, A., Ernst, M., Böckmann, A., & Meier, B. H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201008276 · Cited by 154
Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease
Yanagisawa, D., Shirai, N., Amatsubo, T., Taguchi, H., Hirao, K., Urushitani, M., Morikawa, S., Inubushi, T., Kato, M. G., Kato, F., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.142 · Cited by 157
In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148
In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders
Maeda, J., Zhang, M.-R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3076-10.2011 · Cited by 136
Dual‐Function Probe to Detect Protease Activity for Fluorescence Measurement and 19F MRI
Mizukami, S., Takikawa, R., Sugihara, F., Shirakawa, M., & Kikuchi, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806328 · Cited by 142
Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease
Fu, H., Cui, M., Zhao, L., Tu, P., Zhou, K., Dai, J., & Liu, B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00861 · Cited by 136
Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo
Yang, J., Yin, W., Van, R., Yin, K., Wang, P., Zheng, C., Zhu, B., Ran, K., Zhang, C., Kumar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17783-4 · Cited by 123
Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology
Raymond, S. B., Skoch, J. M., Hills, I. D., Nesterov, E. E., Swager, T. M., & Bacskai, B. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0708-7 · Cited by 122
An ultrasensitive electrochemical aptasensor for early diagnosis of Alzheimer’s disease, using a fern leaves-like gold nanostructure
Negahdary, M., & Heli, H. (2019) · Talanta · doi:10.1016/j.talanta.2019.01.109 · Cited by 118
In Vivo mouse imaging and spectroscopy in drug discovery
Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118
Controlled Intracellular Self-Assembly and Disassembly of 19F Nanoparticles for MR Imaging of Caspase 3/7 in Zebrafish
Yuan, Y., Sun, H., Ge, S., Wang, M., Zhao, H., Wang, L., An, L., Zhang, J., Zhang, H., Hu, B., et al. (2014) · ACS Nano · doi:10.1021/nn5062657 · Cited by 116
Sodium MR Imaging Detection of Mild Alzheimer Disease: Preliminary Study
Mellon, E. A., Pilkinton, D. T., Clark, C., Elliott, M. A., Witschey, W. R. T., Borthakur, A., & Reddy, R. D. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1495 · Cited by 115
Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 115
Design Principles and Theory of Paramagnetic Fluorine‐Labelled Lanthanide Complexes as Probes for 19F Magnetic Resonance: A Proof‐of‐Concept Study
Chalmers, K., Luca, E. D., Hogg, N. H. M., Kenwright, A. M., Kuprov, I., Parker, D., Botta, M., Wilson, J. I., & Blamire, A. M. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200902300 · Cited by 114
Challenges for molecular neuroimaging with MRI
Lelyveld, V. S., Atanasijevic, T., & Jasanoff, A. (2010) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.20221 · Cited by 106
Fluorinated contrast agents for magnetic resonance imaging; a review of recent developments
Knight, J. C., Edwards, P. G., & Paisey, S. J. (2011) · RSC Advances · doi:10.1039/c1ra00627d · Cited by 112
Intracellular Self-Assembly and Disassembly of 19F Nanoparticles Confer Respective “Off” and “On” 19F NMR/MRI Signals for Legumain Activity Detection in Zebrafish
Yuan, Y., Ge, S., Sun, H., Dong, X., Zhao, H., An, L., Zhang, J., Wang, J., Hu, B., & Liang, G. (2015) · ACS Nano · doi:10.1021/acsnano.5b00287 · Cited by 105
Quantitative magnetic resonance fluorine imaging: today and tomorrow
Chen, J., Lanza, G. M., & Wickline, S. A. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.87 · Cited by 106
SPION-Enhanced Magnetic Resonance Imaging of Alzheimer's Disease Plaques in AβPP/PS-1 Transgenic Mouse Brain
Sillerud, L. O., Solberg, N. O., Chamberlain, R., Orlando, R. A., Heidrich, J. E., Brown, D. C., Brady, C. I., Jagt, T. A. V., Garwood, M., & Jagt, D. L. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121171 · Cited by 106
Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease
Saido, T. C., & Iwata, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.12.015 · Cited by 102
Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology
Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-187740 · Cited by 104
Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice
Araya, R., Noguchi, T., Yuhki, M., Kitamura, N., Higuchi, M., Saido, T. C., Seki, K., Itohara, S., Kawano, M., Tanemura, K., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.010 · Cited by 98
Amyloid imaging in Alzheimer??s disease
Nordberg, A. K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281a47744 · Cited by 98
Synthesis and Evaluation of Partly Fluorinated Block Copolymers as MRI Imaging Agents
Peng, H., Blakey, I., Dargaville, B. L., Rasoul, F. A., Rose, S., & Whittaker, A. K. (2009) · Biomacromolecules · doi:10.1021/bm801136m · Cited by 97
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
Villemagne, V. L., Fodero‐Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8019-y · Cited by 103
ABCA1 influences neuroinflammation and neuronal death
Karasinska, J. M., de Haan, W., Franciosi, S., Ruddle, P., Fan, J., Kruit, J. K., Stukas, S., Lütjohann, D., Gutmann, D. H., Wellington, C. L., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.018 · Cited by 104
A review of Î²-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93
ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue
Chang, W. M., Dakanali, M., Capule, C. C., Sigurdson, C. J., Yang, J., & Theodorakis, E. A. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200018v · Cited by 90
In vivo detection of amyloid β deposition using 19F magnetic resonance imaging with a 19F-containing curcumin derivative in a mouse model of Alzheimer's disease
Yanagisawa, D., Amatsubo, T., Morikawa, S., Taguchi, H., Urushitani, M., Shirai, N., Hirao, K., Shiino, A., Inubushi, T., & Tooyama, I. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.071 · Cited by 89
Multifunctional Core–Shell Silica Nanoparticles for Highly Sensitive 19F Magnetic Resonance Imaging
Matsushita, H., Mizukami, S., Sugihara, F., Nakanishi, Y., Yoshioka, Y., & Kikuchi, K. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308500 · Cited by 87
Styryl‐Based Compounds as Potential in vivo Imaging Agents for β‐Amyloid Plaques
Li, Q., Min, J., Ahn, Y., Namm, J., Kim, E. M., Lui, R., Kim, H. Y., Ji, Y., Wu, H., Wısnıewskı, T., et al. (2007) · ChemBioChem · doi:10.1002/cbic.200700154 · Cited by 86
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 88
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
Ni, R., Chen, Z., Deán‐Ben, X. L., Voigt, F. F., Kirschenbaum, D. S., Shi, G., Villois, A., Zhou, Q., Crimi, A., Arosio, P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00906-1 · Cited by 84
Current trends in blood biomarker detection and imaging for Alzheimer’s disease
Hu, S., Yang, C., & Luo, H. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114278 · Cited by 84
Molecular Imaging of β-Amyloid Plaques with Near-Infrared Boron Dipyrromethane (BODIPY)-Based Fluorescent Probes
Watanabe, H., Ono, M., Matsumura, K., Yoshimura, M., Kimura, H., & Saji, H. (2013) · Molecular Imaging · doi:10.2310/7290.2013.00049 · Cited by 79
Metalloporphyrins and Functional Analogues as MRI Contrast Agents
Ni, Y. (2008) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/157340508784356789 · Cited by 78
Magnetic resonance imaging of Alzheimer’s disease
Lehéricy, S., Marjańska, M., Mesrob, L., Sarazin, M., & Kinkingnéhun, S. (2006) · European Radiology · doi:10.1007/s00330-006-0341-z · Cited by 75
Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research
Jack, C. R., Marjańska, M., Wengenack, T. M., Reyes, D. A., Curran, G. L., Lin, J., Preboske, G. M., Poduslo, J. F., & Garwood, M. (2007) · The Neuroscientist · doi:10.1177/1073858406295610 · Cited by 76
Longitudinal assessment of Alzheimer's β‐amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging
Braakman, N., Matysik, J., van Duinen, S. G., Verbeek, F. J., Schliebs, R., de Groot, H. J. M., & Alia, A. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20675 · Cited by 77
Systematic Study of Protein Detection Mechanism of Self-Assembling 19F NMR/MRI Nanoprobes toward Rational Design and Improved Sensitivity
Takaoka, Y., Kiminami, K., Mizusawa, K., Matsuo, K., Narazaki, M., Matsuda, T., & Hamachi, I. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203996c · Cited by 77
Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility
Suzuki, T., Miyamoto, H., Nakahari, T., Inoue, I., Suemoto, T., Jiang, B., Hirota, Y., Itohara, S., Saido, T. C., Tsumoto, T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp006 · Cited by 76
Bivalent Ligand Containing Curcumin and Cholesterol as a Fluorescence Probe for Aβ Plaques in Alzheimer’s Disease
Liu, K., Guo, T. L., Chojnacki, J. E., Lee, H., Wang, X., Siedlak, S. L., Rao, W., Zhu, X., & Zhang, S. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200122j · Cited by 75
Recent developments in carbonylation chemistry using [ 13 C]CO, [ 11 C]CO, and [ 14 C]CO
Nielsen, D. U., Neumann, K. T., Lindhardt, A. T., & Skrydstrup, T. (2018) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3645 · Cited by 74
Biological applications of near infrared fluorescence dye probes in monitoring Alzheimer’s disease
Gyasi, Y. I., Pang, Y., Li, X., Gu, J.-X., Cheng, X., Liu, J., Xu, T., & Liu, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111982 · Cited by 73
Monitoring of Biological One-Electron Reduction by 19F NMR Using Hypoxia Selective Activation of an 19F-Labeled Indolequinone Derivative
Tanabe, K., Harada, H., Narazaki, M., Tanaka, K., Inafuku, K., Komatsu, H., Itô, T., Yamada, H., Chujo, Y., Matsuda, T., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904953b · Cited by 72
Fluorine polymer probes for magnetic resonance imaging: quo vadis?
Jirák, D., Gálisová, A., Kolouchová, K., Babuka, D., & Hrubý, M. (2018) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-018-0724-6 · Cited by 69
Push–pull benzothiazole derivatives as probes for detecting β-amyloid plaques in Alzheimer’s brains
Ono, M., Hayashi, S., Kimura, H., Kawashima, H., Nakayama, M., & Saji, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.032 · Cited by 69
Simultaneous dual‐nuclei imaging for motion corrected detection and quantification of 19F imaging agents
Keupp, J., Rahmer, J., Graesslin, I., Mazurkewitz, P., Schaeffter, T., Lanza, G. M., Wickline, S. A., & Caruthers, S. D. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22877 · Cited by 68
Evaluation of molecules based on the electron donor–acceptor architecture as near-infrared β-amyloidal-targeting probes
Fu, H., Cui, M., Tu, P., Pan, Z., & Liu, B. (2014) · Chemical Communications · doi:10.1039/c4cc04907a · Cited by 68
Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer’s disease pathogenic factor
Kim, C.-B., Choi, Y. Y., Song, W. K., & Song, K. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.051205 · Cited by 70
Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.
Kouyoumdjian, H., Zhu, D. C., El-Dakdouki, M. H., Lorenz, K., Chen, J.-J., Li, W., & Huang, X. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002015 · Cited by 59
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice
Sigurdsson, E. M., Wadghiri, Y. Z., Mosconi, L., Blind, J. A., Knudsen, E., Asuni, A. A., Scholtzova, H., Tsui, W. H., Li, Y., Sadowski, M. J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.018 · Cited by 66
In Vivo Near-Infrared Two-Photon Imaging of Amyloid Plaques in Deep Brain of Alzheimer’s Disease Mouse Model
Chen, C., Liang, Z., Zhou, B., Li, X., Lui, C., Ip, N. Y., & Qu, J. Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00306 · Cited by 66
Multi-modal 19F NMR probe using perfluorinated cubic silsesquioxane-coated silica nanoparticles for monitoring enzymatic activity
Tanaka, K., Kitamura, N., Naka, K., & Chujo, Y. (2008) · Chemical Communications · doi:10.1039/b815022b · Cited by 65
19F MRI detection of β-galactosidase activity for imaging of gene expression
Mizukami, S., Matsushita, H., Takikawa, R., Sugihara, F., Shirakawa, M., & Kikuchi, K. (2011) · Chemical Science · doi:10.1039/c1sc00071c · Cited by 64
Polyfluorinated Bis-styrylbenzene β-Amyloid Plaque Binding Ligands
Flaherty, D. P., Walsh, S. M., Kiyota, T., Dong, Y., Ikezu, T., & Vennerstrom, J. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070085f · Cited by 64
Amyloid imaging: Past, present and future perspectives
Villemagne, V. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.005 · Cited by 68
In Vivo Detection of Cerebral Amyloid Fibrils with Smart Dicynomethylene-4H-Pyran-Based Fluorescence Probe
Cheng, Y., Zhu, B., Deng, Y., & Zhang, Z. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00017 · Cited by 64
Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease
Liu, X., Su, X., Chen, M., Xie, Y., & Li, M. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115840 · Cited by 63
Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases
Giacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 71
Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
Hoffmann, N. A., Dorostkar, M. M., Blumenstock, S., Goedert, M., & Herms, J. W. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-82 · Cited by 69
Multiplexed Imaging of Therapeutic Cells with Multispectrally Encoded Magnetofluorescent Nanocomposite Emulsions
Lim, Y. T., Noh, Y., Cho, J., Han, J. H., Choi, B. S., Kwon, J.-N., Hong, K. S., Gokarna, A., Cho, Y., & Chung, B. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904472z · Cited by 60
Quantitative analysis of amyloid plaques in a mouse model of Alzheimer’s disease by phase-contrast X-ray computed tomography
Noda-Saita, K., Yoneyama, A., Shitaka, Y., Hirai, Y., Terai, K., Wu, J., Takeda, T., Hyodo, K., Osakabe, N., Yamaguchi, T., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.036 · Cited by 58
Dual 19F/1H MR Gene Reporter Molecules for in Vivo Detection of β-Galactosidase
Yu, J.-X., Kodibagkar, V. D., Hallac, R. R., Liu, L., & Mason, R. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200647q · Cited by 54
microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models
Alrfaei, B. M., Vemuganti, R., & Kuo, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080865 · Cited by 54
Gd3+ complexes conjugated to Pittsburgh compound B: potential MRI markers of β-amyloid plaques
Martins, A. F., Morfin, J., Geraldes, C. F. G. C., & Tóth, É. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1055-8 · Cited by 57
Bimodal Quantitative Monitoring for Enzymatic Activity with Simultaneous Signal Increases in 19F NMR and Fluorescence Using Silica Nanoparticle-Based Molecular Probes
Tanaka, K., Kitamura, N., & Chujo, Y. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100381x · Cited by 52
PicoGreen: a better amyloid probe than Thioflavin-T
Mora, A. K., Singh, P. K., Patro, B. S., & Nath, S. (2016) · Chemical Communications · doi:10.1039/c6cc05600h · Cited by 52
Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
Pansieri, J., Gerstenmayer, M., Lux, F., Mériaux, S., Tillement, O., Forge, V., Larrat, B., & Marquette, C. (2018) · Nanomaterials · doi:10.3390/nano8090740 · Cited by 52
Multiphoton in vivo imaging of amyloid in animal models of Alzheimer’s disease
Dong, J., Revilla-Sanchez, R., Moss, S. J., & Haydon, P. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.007 · Cited by 51
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice
Petiet, A., Santin, M. D., Bertrand, A., Wiggins, C. J., Petit, F., Houitte, D., Hantraye, P., Bénavidès, J., Debeir, T., Rooney, T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.009 · Cited by 54
Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 54
Synthesis and evaluation of partly fluorinated polyelectrolytes as components in 19F MRI-detectable nanoparticles
Nurmi, L., Peng, H., Seppälä, J. V., Haddleton, D. M., Blakey, I., & Whittaker, A. K. (2010) · Polymer Chemistry · doi:10.1039/c0py00035c · Cited by 50
Visualization of neuritic plaques in Alzheimer’s disease by polarization-sensitive optical coherence microscopy
Baumann, B., Wöehrer, A., Ricken, G., Augustin, M., Mitter, C., Pircher, M., Kovács, G. G., & Hitzenberger, C. K. F. (2017) · Scientific Reports · doi:10.1038/srep43477 · Cited by 49
Ultra-High Field 7T MRI: A New Tool for Studying Alzheimer's Disease
Kerchner, G. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0023 · Cited by 49
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease
Larbanoix, L., Burtéa, C., Laurent, S., LEUVEN, F. V., Toubeau, G., Elst, L. V., & Müller, R. N. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.021 · Cited by 49

Authors: Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C.
Affiliations: RIKEN Center for Brain Science (JP)
Corresponding author: Higuchi, Makoto
Saido, Takaomi C
ORCID: Higuchi, Makoto
Iwata, Nobuhisa
Saido, Takaomi C
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2005-03-13
Volume: 8
Issue: 4
Pages: 527-533
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn1422
OpenAlex: W1989252530
Cited by: 339
References: 32
Citations by year: 2026: 3 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 14 · 2020: 7 · 2019: 3 · 2018: 15 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 17 · 2013: 27 · 2012: 15
FWCI: 17.38
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Funders: RIKEN
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords: amyloid plaques, Alzheimer's disease, 19F MRI, 1H MRI, amyloid imaging, amyloid precursor protein transgenic mice, non-invasive brain imaging, presymptomatic diagnosis, disease biomarkers
MeSH terms: Age Factors, Alzheimer Disease, Amyloidosis, Animals, Brain, Brain Chemistry, Cell Count, Disease Models, Animal, Dose-Response Relationship, Drug, Fluorescent Dyes, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Memantine, Mice, Transgenic, Phosphopyruvate Hydratase, Radionuclide Imaging, Staining and Labeling, Time Factors, Tritium, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Imaging, Three-Dimensional, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

19F and 1H MRI detection of amyloid β plaques in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks